Cullinan Therapeutics, Inc. (CGEM)
NASDAQ·Healthcare·Biotechnology
$17.69
+8.86%
Mkt Cap $1.01B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (16 analysts)
$31.25
Range $28.00 – $37.00
Implied Upside
+76.7%
Consensus $31.25 vs current $17.69
NASDAQ·Healthcare·Biotechnology
$17.69
+8.86%
Mkt Cap $1.01B
Buy
9
Hold
0
Sell
0
Price Target (16 analysts)
$31.25
Range $28.00 – $37.00
+76.7%
Consensus $31.25 vs current $17.69